Generare Bioscience
GB
GE

Generare Bioscience

Generating never-before-seen molecular data for drug development using artificial intelligence.

2023ActiveParis, France

About

Generare Bioscience is a biotechnology company focused on generating novel molecular data for drug development. They leverage artificial intelligence to discover and advance new drugs.

Key facts

At-a-glance profile data

Headquarters
Paris, France
Founded
2023
Total funding
$23M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by Generare Bioscience
DateRoundAmountLead investors
2 Apr 2026Series A$23MAlven, Daphni
Add first review

Frequently asked

How much funding has Generare Bioscience raised?

Generare Bioscience has raised a total of $23M in funding. The most recent round on record is Series A.